Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D00446 (
Sucralfate
)
278
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This clinical study was undertaken to test the efficacy of topical
Sucralfate
Cream in second and third degree burns. Topical
Sucralfate
Cream has been used on a wide variety of lesions from radiation proctitis and dermatitis to
keratoconjunctivitis
with remarkable results. The study was carried out in two phases. The first phase comprised 60 patients, 30 of whom were treated with
Sucralfate
Cream while the other 30 were treated with other topical antimicrobial agents. Twenty-one of the patients in the study group had second-degree burns and nine patients' third degree burns. In the second phase, a double blind study was carried out on 25 patients where one area of burns was treated with
Sucralfate
Cream while another control area of the same patient was treated with a placebo ointment, containing the excipients used during preparation of the
Sucralfate
Cream, without
Sucralfate
. In the first phase, it was seen that the period of epithelialisation of second degree burns in the study group treated with
Sucralfate
Cream was 18.8 days compared with 24.6 days with other topical agents. This difference is statistically significant with a P value of <0.00001. In the double blind study, also healing in the areas treated with
Sucralfate
was more rapid than those treated with bland placebo ointment. The difference in the two rates of healing was statistically significant with a P value of 0.00067. Histopathological studies were also carried out in 10 patients of phase I of the trial.
Sucralfate
Cream promotes rapid epithelialisation of second degree burns with minimal said effects and offers another topical agent in the burn care specialist's armamentarium.
...
PMID:Topical use of Sucralfate Cream in second and third degree burns. 1145 99